Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.8 (
cholinesterase
)
12,691
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We noticed a Japanese male showed low serum
butyrylcholinesterase
(
BCHE
) activity on health examination. The phenotyping analysis revealed a reduced dibucaine number (DN) and an especially low fluoride number (FN), similar to an FS phenotype. A homozygous missense mutation, a T to A transversion at nucleotide 988, was identified in his
BCHE
gene. This mutation resulted in the replacement of leucine by isoleucine at codon 330 (L330I). DN and FN of recombinant
BCHE
(L330I) secreted by human
fetal kidney
cells were compared to recombinant wild-type(usual gene)
BCHE
and normal serum
BCHE
. These results showed this amino acid substitution of
BCHE
, Leu330 to Ile, really caused the abnormal DN and FN. We conclude that the
BCHE
L330I mutation is a fluoride-resistant gene, a Japanese type fluoride-resistant gene.
...
PMID:Human butyrylcholinesterase L330I mutation belongs to a fluoride-resistant gene, by expression in human fetal kidney cells. 938 84